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Abstract
Background: Mortality predictions calculated using scoring scales are often not accurate in
populations other than those in which the scales were developed because of differences in case-mix.
The present study investigates the effect of first-level customization, using a logistic regression
technique, on discrimination and calibration of the Acute Physiology and Chronic Health Evaluation
(APACHE) II and III scales.
Method: Probabilities of hospital death for patients were estimated by applying APACHE II and III and
comparing these with observed outcomes. Using the split sample technique, a customized model to
predict outcome was developed by logistic regression. The overall goodness-of-fit of the original and
the customized models was assessed.
Results: Of 3383 consecutive intensive care unit (ICU) admissions over 3 years, 2795 patients could
be analyzed, and were split randomly into development and validation samples. The discriminative
powers of APACHE II and III were unchanged by customization (areas under the receiver operating
characteristic [ROC] curve 0.82 and 0.85, respectively). Hosmer–Lemeshow goodness-of-fit tests
showed good calibration for APACHE II, but insufficient calibration for APACHE III. Customization
improved calibration for both models, with a good fit for APACHE III as well. However, fit was different
for various subgroups.
Conclusions: The overall goodness-of-fit of APACHE III mortality prediction was improved significantly
by customization, but uniformity of fit in different subgroups was not achieved. Therefore, application of
the customized model provides no advantage, because differences in case-mix still limit comparisons
of quality of care.
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Introduction
Scoring systems are used in intensive care to control for
various case-mix factors in order to compare patient popu-
lations. Score-based predictions of mortality in ICU
patients may be used for quality assurance and compari-
son of quality of care [1–3]. If a scoring system is intended
to be used in a patient population that is different from the
original population used in the development of the system
(development sample), then it should be validated in this
new population [4–7].
Calibration measures how closely mortality prognosis fits the
observed mortality. Poor calibration in a patient sample does
not necessarily mean that the quality of care in that particular
ICU is better or worse than in the development sample.
Several clinical case-mix as well as nonclinical factors are
not accounted for by such scoring systems [8]. The overall
fit of a score in a particular patient sample can be
improved by customization using logistic regression. This
is possible for the whole population in question [9], but
can also be done independently for specific subgroups
[10,11]. In the latter case, the customized score can only
be used in this subset of patients. If a customized model
derived from the whole population is used, then uniformity
of fit for the relevant subgroups should still be tested.
Knowledge of the influence of subgroups is important,
because future changes in case-mix may compromise the
improvement achieved by customization.
The aim of the present study was to test the performance
of APACHE II and III, after customization of these scales
for use in future assessment of quality of care in our unit.
Patients and methods
Patients
Over a 3-year period (October 1991–October 1994),
3382 patients were consecutively admitted to the 12-bed
interdiciplinary ICU of a 571-bed, university-affiliated com-
munity hospital. For the APACHE II analysis, 274 patients
who were readmitted to the ICU, 208 patients who were
in the ICU for less than 4 h, 16 patients who were admit-
ted for dialysis only, two patients who were younger than
16 years and 87 patients with missing data were
excluded. Thus, 2795 patients were included in the analy-
sis. For APACHE III, 79 patients who were admitted to
rule out myocardial infarction and 55 cardiosurgical
patients were excluded, leaving 2661 for analysis.
Data collection
Data collection was done according to the criteria and
definitions described by the developers of APACHE II and
III [12,13]. The data were collected by ward doctors after
4 weeks training in how to use the APACHE system. They
had access to a detailed manual, including definitions and
procedures. Constant supervision by a documentation
assistant included regular comparison of the original with
the collected data, and review of completeness. In order
to assess reliability of data collection, data from a random
sample of 50 patients were recorded by two data collec-
tors independently. Interobserver reliability was analyzed
by Kendall’s coefficient of concordance and k statistics. In
addition, data collection software, which was provided by
APACHE Medical Systems Inc (Washington, DC), auto-
matically checked that the data were plausible. The whole
data set was tested using a box-plot technique in order to
analyze extreme values seperately. Vital status at hospital
discharge was recorded.
Statistical analysis
The sample was split randomly into a development
(n = 1863 for APACHE II and n = 1772 for APACHE III)
and a validation sample (n = 932 for APACHE II and
n = 889 for APACHE III). Development of the original model
by logistic regression [14] led to the following equation:
logit(or) = b0 + Sbi × xi (1)
where b0 is a constant, bi are coefficients, and xi encom-
passes the various patient factors that are included in
the model. The probability of hospital death is calculated
as follows:
P(or) = elogit(or)/1 + elogit(or) (2)
In the present study the APACHE II equation was used as
indicated by the developers [12]. The APACHE III equa-
tion was provided by APACHE Medical Systems Inc, and
it has not been published for commercial reasons. In cus-
tomizing the scales, the original logit was used as the
independent variable and hospital death was used as the
dependent variable. The new probability of hospital death
was calculated as follows:
P(cust) = elogit(cust)/1 + elogit(cust) (3)
and logit(cust) is calculated as follows:
logit(cust) = bc
0 + [bc
1 × logit(or)] (4)
where bc
0 is the constant and bc
1 the coefficient derived
by logistic regression. The customized coefficients were
calculated to be those shown in Table 1.
Discrimination and calibration were analyzed for the origi-
nal and customized models. Discriminative power was
tested by calculating the areas under the ROC curves
[15], and calibration was calculated using standardized
mortality ratio (SMR; observed deaths/expected deaths),
with 95% confidence intervals [16], and using the
Hosmer–Lemeshow goodness-of-fit H and C tests [17].
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was done by c2 test and Mann–Whitney U test, because
values were not normally distributed.
Statistical analysis was performed using the SPSS 6.1
software package (SPSS, Chicago, IL, USA). P < 0.05
was considered statistically significant.
Results
Completeness of data was good; excluding just one vari-
able (24-h urine), 94.6% of all necessary data were col-
lected on average for each patient; 24-h urine was
available in only 78.1% of patients. Reliability analysis
revealed Kendall’s coefficients for clinical and laboratory
data above 0.9 except for blood gas values (0.878) and
24-h urine (0.870). k values were low only for diagnosis of
renal failure (0.49) and Glasgow Coma Scale score
(0.54). Despite that, differences in calculated scores were
very low, with Kendall’s coefficients above 0.92. Thus,
overall reliability of data collection was good.
Demographic and clinical characteristics were very similar
for the development and validation samples (Table 2), and
no significant differences were detected. Both models
showed good discrimination, which was unchanged by
customization.
The original APACHE II prediction calibrated adequately in
the patients studied, with minor improvements after cus-
tomization. APACHE III originally showed inadequate cali-
bration, which was considerably improved by customization,
and was adequate afterwards (Table 3). The calibration
curves (Fig. 1) reveal that calibration after customization
was good for APACHE II up to the 70–80% mortality risk
decile, but was still far from ideal for APACHE III. When
interpreting the greater deviations from the ideal line in the
80–90% and 90–100% deciles, the small numbers of
cases in these groups have to be borne in mind.
Subgroup analysis of the validation sample is shown in
Table 4 for APACHE II and in Table 5 for APACHE III. Fit
was not uniform for APACHE II, with varying SMRs. Good-
ness-of-fit was insufficient for patients younger than 65
years and for those directly admitted. Although goodness-
of-fit improved for most subgroups after customization, it
was still not uniform. These findings were similar for
APACHE III. Goodness-of-fit was insufficient for medical,
younger, directly admitted and cardiovascular patients. Fit
was improved for all but younger and transferred patients.
However, it was still not uniform after customization.
Discussion
Customization of APACHE II and III in a large patient pop-
ulation from a single unit led to an improvement in the
overall goodness-of-fit of APACHE III, which showed poor
calibration in its original version. Despite a similar improve-
ment of fit in several subgroups that were large enough to
be tested, good uniformity of fit was not achieved.
These results are comparable with those of a large multi-
center study [9] that analyzed customization of the Mortal-
ity Prediction Model. In that study, a second-level
customization, in which new coefficients were developed
for all single patient factors included in the original model,
improved calibration even further. Second-level customiza-
tion was not attempted in the present patient sample
because there were not enough patients for that purpose.
Time to collect data in a sufficiently large patient sample in
a single unit would probably be so great that real changes
in case-mix or ICU treatment might occur during the study,
which would confound the results. First-level customiza-
tion will probably be a more practical method for single
Available online http://ccforum.com/content/5/1/031
Table 1
Customized coefficients used in the calculation of probability
of hospital death
Coefficient
Model bc
0 bc
1
APACHE II 0.1926 1.0686
APACHE III 0.4022 1.0177
Table 2
Demographic and clinical data for APACHE II sample
Patient characteristic Development Validation
Cases (n) 1863 932
Age (mean ± SD) 62.5 ± 16.1 61.8 ± 16.3
Medical (%) 65.5 66.0
Surgical (%) 34.5 34.0
Direct admission (%) 69.9 68.1
Referral (%) 30.1 31.9
<65 years (%) 49.1 52.0
³65 years (%) 50.9 48.0
Cardiovascular (%) 38.9 38.6
Gastrointestinal (%) 32.9 31.8
DOS ICU (mean ± SD) 3.95 ± 7.0 3.48 ± 5.4
DOS hospital (mean ± SD) 25.35 ± 22.4 25.26 ± 22.5
Hospital mortality (%) 18.5 17.2
APACHE II prediction (%) 17.3 16.6
APACHE III prediction (%) 14.7 14.7
There were no differences for the APACHE III sample (1772/889
cases). Direct admission is defined as admission from emergency room,
operating theatre, or recovery room; and transferral is defined as
admission from other hospital, other ICU, or floor. DOS, duration of stay.units to improve the overall fit of score systems that are to
be used for quality assessment.
At present, however, we would not recommend cus-
tomization routinely. This is because a major problem is
still unresolved; although good calibration can be
achieved for the whole patient sample, uniformity of fit
remains unsatisfactory. This is the case even for APACHE
III, which accounts for more case-mix factors, such as
diagnostic categories and lead time, than do the other
models. Nevertheless, achievement of uniformity is impor-
tant, because change in case-mix over time will otherwise
lead to a loss of accuracy of a customized model. It would
be difficult to interpret whether a change in the mortality
ratio over time would be due to a change in quality of care
or in case-mix.
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Table 3
Discrimination and calibration of APACHE II and III before and after customization
Prediction Sample n ROC area H C SMR (95% CI)
APACHE II original Development 1863 0.817 10.46 9.38 1.07 (0.98–1.16)
Validation 932 0.826 8.02 10.68 1.04 (0.91–1.16)
APACHE II customized Development 1863 0.817 9.37 5.53 1.00 (0.92–1.08)
Validation 932 0.826 6.23 8.59 0.97 (0.85–1.09)
APACHE III original Development 1772 0.849 34.30† 34.96† 1.25 (1.15–1.34)
Validation 889 0.863 20.13* 20.19* 1.18 (1.05–1.31)
APACHE III customized Development 1772 0.849 7.29 6.14 1.00 (0.92–1.08)
Validation 889 0.863 15.10 11.72 0.94 (0.83–1.06)
*P = 0.01, †P < 0.001. C, Hosmer–Lemeshow goodness-of-fit C test; H, Hosmer–Lemeshow goodness-of-fit H test; CI, confidence interval.
Figure 1
Calibration curves for APACHE II and APACHE III before and after customization for development and validation samples. The diagonal line is the
line of ideal correspondence between observed and expected mortality. The solid line represents the development sample and the dotted line the
validation sample. Case numbers for the development sample are represented by white bars, and those of the validation sample by grey bars.If a customized model still has a poor fit for a certain sub-
group at a specific unit, then customization for this sample
can be attempted separately [10,11]. This could be
attempted in medical and cardiovascular patients at our
unit for APACHE III, because these groups are sufficiently
large and because general customization did not lead to a
good fit. However, the practicality of such an approach is
questionable.
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Table 4
Discrimination and calibration of APACHE II before and after customization for various subgroups of the validation sample
Subgroup Prediction n ROC area H C SMR (95% CI)
Medical Original 615 0.842 5.89 12.08 1.08 (0.94–1.23)
Customized 0.842 7.90 9.65 1.01 (0.88–1.15)
Surgical Original 317 0.758 5.48 7.15 0.91 (0.65–1.18)
Customized 0.758 6.87 7.53 0.86 (0.60–1.11)
<65 years Original 485 0.859 14.31 20.13† 0.91 (0.70–1.13)
Customized 0.859 8.82 19.90* 0.86 (0.66–1.07)
³65 years Original 447 0.774 8.09 8.31 1.11 (0.96–1.27)
Customized 0.774 7.16 7.27 1.04 (0.89–1.19)
Direct admission Original 635 0.816 12.12 16.01* 0.99 (0.82–1.10)
Customized 0.816 7.98 15.57* 0.93 (0.77–1.10)
Transferral Original 297 0.814 3.05 3.90 1.10 (0.87–1.23)
Customized 0.814 7.06 2.74 1.03 (0.85–1.20)
Cardiovascular Original 360 0.879 9.21 11.13 1.05 (0.86–1.24)
Customized 0.879 10.44 8.83 0.99 (0.80–1.17)
Gastrointestinal Original 296 0.855 11.12 12.82 0.76 (0.53–0.98)
Customized 0.855 12.31 13.73 0.71 (0.49–0.92)
Direct admission is defined as admission from emergency room, operating theatre, or recovery room; and transferral is defined as admission from
other hospital, other ICU, or floor. C, Hosmer–Lemeshow goodness-of-fit C test; H, Hosmer–Lemeshow goodness-of-fit H test; CI, confidence
interval. *P < 0.05, †P = 0.01.
Table 5
Discrimination and calibration of APACHE III before and after customization for various subgroups of the validation sample
Subgroup Prediction n ROC area H C SMR (95% CI)
Medical Original 590 0.861 22.01† 24.90† 1.15 (1.01–1.29)
Customized 0.861 15.83* 18.27* 0.93 (0.81–1.06)
Surgical Original 299 0.842 8.51 13.18 1.28 (0.96–1.60)
Customized 0.842 4.75 7.62 0.98 (0.71–1.25)
<65 years Original 464 0.894 16.62* 15.59* 1.19 (0.95–1.42)
Customized 0.894 21.24† 10.19 0.94 (0.74–1.14)
³65 years Original 425 0.812 13.63 15.74* 1.17 (1.02–1.33)
Customized 0.812 12.93 9.42 0.95 (0.81–1.08)
Direct admission Original 614 0.874 19.41* 23.46† 1.29 (1.10–1.48)
Customized 0.874 9.07 11.67 1.02 (0.86–1.18)
Transferral Original 275 0.817 9.54 12.18 1.05 (0.87–1.23)
Customized 0.817 15.80* 15.18* 0.86 (0.70–1.01)
Cardiovascular Original 317 0.890 16.72* 19.21* 1.11 (0.92–1.35)
Customized 0.890 18.47* 15.61* 0.90 (0.74–1.07)
Gastrointestinal Original 296 0.887 8.17 5.56 1.08 (0.81–1.34)
Customized 0.887 7.80 5.26 0.85 (0.62–1.08)
Direct admission is defined as admission from emergency room, operating theatre, or recovery room; and transferral is defined as admission from
other hospital, other ICU, or floor. C, Hosmer–Lemeshow goodness-of-fit C test; H, Hosmer–Lemeshow goodness-of-fit H test; CI, confidence
interval. *P < 0.05, †P = 0.01.We conclude that the customized models of APACHE II
and III did not provide an advantage over the original ver-
sions. First-level customization did not solve the problem
of differences in case-mix, leading to different score
results, which do not necessarily reflect differences in
quality of care [18]. Data collection is ongoing to test vari-
ation in the original and customized scores over time in a
second large sample from our unit.
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